Journal Article

A Role of Inflammation in Charcot–Marie–Tooth Disorders—In a Perspective of Treatment?

Kochański, Andrzej, Kamińska, Joanna

2024

Overview

Despite the fact that there are published case reports and model work providing evidence of inflammation in Charcot–Marie–Tooth disorders (CMTs), in clinical practice, CMT and inflammatory neuropathies are always classified as two separate groups of disorders. This sharp separation of chronic neuropathies into two groups has serious clinical implications. As a consequence, the patients harboring CMT mutations are practically excluded from pharmacological anti-inflammatory treatments. In this review, we present that neuropathological studies of peripheral nerves taken from some patients representing familial aggregation of CMTs revealed the presence of inflammation within the nerves. This shows that neurodegeneration resulting from germline mutations and the inflammatory process are not mutually exclusive. We also point to reports demonstrating that, at the clinical level, a positive response to anti-inflammatory therapy was observed in some patients diagnosed with CMTs, confirming the role of the inflammatory component in CMT. We narrowed a group of more than 100 genes whose mutations were found in CMT-affected patients to the seven most common (MPZ, PMP22, GJB1, SEPT9, LITAF, FIG4, and GDAP1) as being linked to the coexistence of hereditary and inflammatory neuropathy. We listed studies of mouse models supporting the idea of the presence of an inflammatory process in some CMTs and studies demonstrating at the cellular level the presence of an inflammatory response. In the following, we discuss the possible molecular basis of some neuropathies involving neurodegenerative and inflammatory processes at both the clinical and morphological levels. Finally, we discuss the prospect of a therapeutic approach using immunomodulation in some patients affected by CMTs.

• Publisher: MDPI AG,MDPI
• Subject: Animals / Anti-inflammatory agents / Anti-Inflammatory Agents - therapeutic use / Charcot-Marie-Tooth Disease - drug therapy / Charcot-Marie-Tooth Disease - genetics / Charcot-Marie-Tooth Disease - pathology / Charcot-Marie-Tooth Disease - therapy / Disease / Disease Models, Animal / Genes / Humans / Immunoglobulins / Inflammation / Inflammation - genetics / Inflammation - pathology / Multiple sclerosis / Mutation / Pathogenesis / Patients / Review